Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Confidence in the National Immunization Program among parents in Sweden 2016 - A cross-sectional survey.

Byström E, Lindstrand A, Bergström J, Riesbeck K, Roth A.

Vaccine. 2020 Feb 11. pii: S0264-410X(20)30120-1. doi: 10.1016/j.vaccine.2020.01.078. [Epub ahead of print]

2.

Complement evasion by the human respiratory tract pathogens Haemophilus influenzae and Moraxella catarrhalis.

Riesbeck K.

FEBS Lett. 2020 Feb 13. doi: 10.1002/1873-3468.13758. [Epub ahead of print] Review.

PMID:
32053211
3.

A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease.

Uddén F, Ahl J, Littorin N, Strålin K, Athlin S, Riesbeck K.

mSphere. 2020 Feb 5;5(1). pii: e00925-19. doi: 10.1128/mSphere.00925-19.

4.

Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.

Thornton RB, Hakansson A, Hood DW, Nokso-Koivisto J, Preciado D, Riesbeck K, Richmond PC, Su YC, Swords WE, Brockman KL.

Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1:109838. doi: 10.1016/j.ijporl.2019.109838. Epub 2019 Dec 19.

PMID:
31879085
5.

Pseudomonas aeruginosa uses multiple receptors for adherence to laminin during infection of the respiratory tract and skin wounds.

Paulsson M, Su YC, Ringwood T, Uddén F, Riesbeck K.

Sci Rep. 2019 Dec 3;9(1):18168. doi: 10.1038/s41598-019-54622-z.

6.

Risk factors associated with prolonged intestinal colonization of ESBL-producing Enterobacteriaceae - a prospective cohort study.

Ljungquist O, Schönbeck M, Riesbeck K, Tham J.

Infect Drug Resist. 2019 Aug 26;12:2637-2648. doi: 10.2147/IDR.S205163. eCollection 2019.

7.

C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.

Bettoni S, Shaughnessy J, Maziarz K, Ermert D, Gulati S, Zheng B, Mörgelin M, Jacobsson S, Riesbeck K, Unemo M, Ram S, Blom AM.

JCI Insight. 2019 Dec 5;4(23). pii: 131886. doi: 10.1172/jci.insight.131886.

8.

HAMLET, a protein complex from human milk has bactericidal activity and enhances the activity of antibiotics against pathogenic Streptococci.

Alamiri F, Riesbeck K, Hakansson AP.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01193-19. doi: 10.1128/AAC.01193-19. [Epub ahead of print]

PMID:
31591115
9.
10.

Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial.

Ljungquist O, Kampmann C, Resman F, Riesbeck K, Tham J.

Clin Microbiol Infect. 2019 Sep 5. pii: S1198-743X(19)30481-1. doi: 10.1016/j.cmi.2019.08.019. [Epub ahead of print]

11.

Inflammation Biomarkers and Correlation to Wound Status After Full-Thickness Skin Grafting.

Saleh K, Strömdahl AC, Riesbeck K, Schmidtchen A.

Front Med (Lausanne). 2019 Jul 12;6:159. doi: 10.3389/fmed.2019.00159. eCollection 2019.

12.

Erratum for Stephan et al., "Honeybee-Specific Lactic Acid Bacterium Supplements Have No Effect on American Foulbrood-Infected Honeybee Colonies".

Stephan JG, Lamei S, Pettis JS, Riesbeck K, de Miranda JR, Forsgren E.

Appl Environ Microbiol. 2019 Jul 18;85(15). pii: e01321-19. doi: 10.1128/AEM.01321-19. Print 2019 Aug 1. No abstract available.

13.

The Laminin Interactome: A Multifactorial Laminin-Binding Strategy by Nontypeable Haemophilus influenzae for Effective Adherence and Colonization.

Su YC, Mattsson E, Singh B, Jalalvand F, Murphy TF, Riesbeck K.

J Infect Dis. 2019 Aug 9;220(6):1049-1060. doi: 10.1093/infdis/jiz217.

PMID:
31034569
14.

Honeybee-Specific Lactic Acid Bacterium Supplements Have No Effect on American Foulbrood-Infected Honeybee Colonies.

Stephan JG, Lamei S, Pettis JS, Riesbeck K, de Miranda JR, Forsgren E.

Appl Environ Microbiol. 2019 Jun 17;85(13). pii: e00606-19. doi: 10.1128/AEM.00606-19. Print 2019 Jul 1. Erratum in: Appl Environ Microbiol. 2019 Jul 18;85(15):.

15.

Moonlighting of Haemophilus influenzae heme acquisition systems contributes to the host airway-pathogen interplay in a coordinated manner.

Rodríguez-Arce I, Al-Jubair T, Euba B, Fernández-Calvet A, Gil-Campillo C, Martí S, Törnroth-Horsefield S, Riesbeck K, Garmendia J.

Virulence. 2019 Dec;10(1):315-333. doi: 10.1080/21505594.2019.1596506.

16.

Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels.

Holmdahl T, Odenholt I, Riesbeck K, Medstrand P, Widell A.

Infect Dis (Lond). 2019 Mar;51(3):197-205. doi: 10.1080/23744235.2018.1546056. Epub 2019 Jan 16.

PMID:
30646786
17.

EF-Tu From Non-typeable Haemophilus influenzae Is an Immunogenic Surface-Exposed Protein Targeted by Bactericidal Antibodies.

Thofte O, Su YC, Brant M, Littorin N, Duell BL, Alvarado V, Jalalvand F, Riesbeck K.

Front Immunol. 2018 Dec 18;9:2910. doi: 10.3389/fimmu.2018.02910. eCollection 2018.

18.

Anti-EF-Tu IgG titers increase with age and may contribute to protection against the respiratory pathogen Haemophilus influenzae.

Thofte O, Kaur R, Su YC, Brant M, Rudin A, Hood D, Riesbeck K.

Eur J Immunol. 2019 Mar;49(3):490-499. doi: 10.1002/eji.201847871. Epub 2019 Jan 3.

19.

Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease.

Littorin N, Uddén F, Ahl J, Resman F, Slotved HC, Athlin S, Riesbeck K.

Front Microbiol. 2018 Nov 15;9:2746. doi: 10.3389/fmicb.2018.02746. eCollection 2018.

20.

Differential distribution of IgA-protease genotypes in mucosal and invasive isolates of Haemophilus influenzae in Sweden.

Resman F, Manat G, Lindh V, Murphy TF, Riesbeck K.

BMC Infect Dis. 2018 Nov 22;18(1):592. doi: 10.1186/s12879-018-3464-3.

21.

The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Su YC, Jalalvand F, Thegerström J, Riesbeck K.

Front Immunol. 2018 Nov 5;9:2530. doi: 10.3389/fimmu.2018.02530. eCollection 2018. Review.

22.

Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance.

Singh B, Mostajeran M, Su YC, Al-Jubair T, Riesbeck K.

J Vis Exp. 2018 Oct 16;(140). doi: 10.3791/54653.

PMID:
30394376
23.

Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen Moraxella catarrhalis.

Laabei M, Liu G, Ermert D, Lambris JD, Riesbeck K, Blom AM.

J Immunol. 2018 Nov 1;201(9):2721-2730. doi: 10.4049/jimmunol.1800734. Epub 2018 Sep 28.

24.

Helicobacter pylori Outer Membrane Vesicles Protect the Pathogen From Reactive Oxygen Species of the Respiratory Burst.

Lekmeechai S, Su YC, Brant M, Alvarado-Kristensson M, Vallström A, Obi I, Arnqvist A, Riesbeck K.

Front Microbiol. 2018 Sep 7;9:1837. doi: 10.3389/fmicb.2018.01837. eCollection 2018.

25.

The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against Haemophilus influenzae in Chronic Obstructive Pulmonary Disease (COPD): Implications for an in vivo Innate Host Defense Function of Collagen VI.

Abdillahi SM, Tati R, Nordin SL, Baumgarten M, Hallgren O, Bjermer L, Erjefält J, Westergren-Thorsson G, Singh B, Riesbeck K, Mörgelin M.

Front Immunol. 2018 Aug 31;9:1988. doi: 10.3389/fimmu.2018.01988. eCollection 2018.

26.

Bacterial Outer Membrane Vesicles Induce Vitronectin Release Into the Bronchoalveolar Space Conferring Protection From Complement-Mediated Killing.

Paulsson M, Che KF, Ahl J, Tham J, Sandblad L, Smith ME, Qvarfordt I, Su YC, Lindén A, Riesbeck K.

Front Microbiol. 2018 Jul 13;9:1559. doi: 10.3389/fmicb.2018.01559. eCollection 2018.

27.

Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication.

Soares RP, Xander P, Costa AO, Marcilla A, Menezes-Neto A, Del Portillo H, Witwer K, Wauben M, Nolte-T Hoen E, Olivier M, Criado MF, da Silva LLP, Abdel Baqui MM, Schenkman S, Colli W, Alves MJM, Ferreira KS, Puccia R, Nejsum P, Riesbeck K, Stensballe A, Hansen EP, Jaular LM, Øvstebø R, de la Canal L, Bergese P, Pereira-Chioccola V, Pfaffl MW, Fritz J, Gho YS, Torrecilhas AC.

J Extracell Vesicles. 2017 Nov 26;6(1):1407213. doi: 10.1080/20013078.2017.1407213. eCollection 2017.

28.

Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study.

Thegerström J, Månsson V, Riesbeck K, Resman F.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1761-1775. doi: 10.1007/s10096-018-3311-x. Epub 2018 Jun 30.

29.

How bacteria hack the matrix and dodge the bullets of immunity.

Paulsson M, Riesbeck K.

Eur Respir Rev. 2018 Jun 27;27(148). pii: 180018. doi: 10.1183/16000617.0018-2018. Print 2018 Jun 30. Review.

30.

Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.

Jalalvand F, Riesbeck K.

Expert Rev Vaccines. 2018 Jun;17(6):503-512. doi: 10.1080/14760584.2018.1484286. Epub 2018 Jun 18. Review.

PMID:
29863956
31.

A novel PBP3 substitution in Haemophilus influenzae confers reduced aminopenicillin susceptibility.

Thegerström J, Matuschek E, Su YC, Riesbeck K, Resman F.

BMC Microbiol. 2018 May 31;18(1):48. doi: 10.1186/s12866-018-1196-6.

32.

Titanium granules pre-treated with hydrogen peroxide inhibit growth of bacteria associated with post-operative infections in spine surgery.

Ohlin A, Mattsson E, Mörgelin M, Davies JR, Svensäter G, Corvec S, Tengvall P, Riesbeck K.

Eur Spine J. 2018 Oct;27(10):2463-2468. doi: 10.1007/s00586-018-5619-8. Epub 2018 May 7.

PMID:
29736803
33.

Aerobic bacteria associated with chronic suppurative otitis media in Angola.

Uddén F, Filipe M, Reimer Å, Paul M, Matuschek E, Thegerström J, Hammerschmidt S, Pelkonen T, Riesbeck K.

Infect Dis Poverty. 2018 May 3;7(1):42. doi: 10.1186/s40249-018-0422-7.

34.

Capsule Typing of Haemophilus influenzae by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Månsson V, Gilsdorf JR, Kahlmeter G, Kilian M, Kroll JS, Riesbeck K, Resman F.

Emerg Infect Dis. 2018 Mar;24(3):443-452. doi: 10.3201/eid2403.170459.

35.

Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome.

van den Heuvel L, Riesbeck K, El Tahir O, Gracchi V, Kremlitzka M, Morré SA, van Furth AM, Singh B, Okrój M, van de Kar N, Blom AM, Volokhina E.

J Hum Genet. 2018 Jan;63(1):93-96. doi: 10.1038/s10038-017-0356-0. Epub 2017 Nov 13.

PMID:
29215086
36.

Hemolytic Uremic Syndrome Associated With Pneumococci in Children-An Elusive Mystery Now Explained?

Riesbeck K.

J Infect Dis. 2018 Jan 17;217(3):341-343. doi: 10.1093/infdis/jix306. No abstract available.

PMID:
28968866
37.

Haemophilus Protein F Orthologs of Pathogens Infecting the Airways: Exploiting Host Laminin at Heparin-Binding Sites for Maximal Adherence to Epithelial Cells.

Su YC, Halang P, Fleury C, Jalalvand F, Mörgelin M, Riesbeck K.

J Infect Dis. 2017 Dec 5;216(10):1303-1307. doi: 10.1093/infdis/jix467.

PMID:
28968674
38.

Fluoroquinolone-Resistant Alcaligenes faecalis Related to Chronic Suppurative Otitis Media, Angola.

Filipe M, Reimer Å, Matuschek E, Paul M, Pelkonen T, Riesbeck K.

Emerg Infect Dis. 2017 Oct;23(10):1740-1742. doi: 10.3201/eid2310.170268.

39.

The Rickettsia conorii Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.

Fish AI, Riley SP, Singh B, Riesbeck K, Martinez JJ.

Front Cell Infect Microbiol. 2017 Mar 1;7:61. doi: 10.3389/fcimb.2017.00061. eCollection 2017.

40.

The crystal structure of PD1, a Haemophilus surface fibril domain.

Wright J, Thomsen M, Kolodziejczyk R, Ridley J, Sinclair J, Carrington G, Singh B, Riesbeck K, Goldman A.

Acta Crystallogr F Struct Biol Commun. 2017 Feb 1;73(Pt 2):101-108. doi: 10.1107/S2053230X17001406. Epub 2017 Jan 31.

41.

PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen Moraxella catarrhalis.

Liu G, Ermert D, Johansson ME, Singh B, Su YC, Paulsson M, Riesbeck K, Blom AM.

J Immunol. 2017 Mar 15;198(6):2330-2340. doi: 10.4049/jimmunol.1601319. Epub 2017 Feb 1.

42.

Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.

Paulsson M, Granrot A, Ahl J, Tham J, Resman F, Riesbeck K, Månsson F.

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1187-1196. doi: 10.1007/s10096-017-2907-x. Epub 2017 Jan 21.

43.

The spread and clinical impact of ST14CC-PBP3 type IIb/A, a clonal group of non-typeable Haemophilus influenzae with chromosomally mediated β-lactam resistance-a prospective observational study.

Månsson V, Skaare D, Riesbeck K, Resman F.

Clin Microbiol Infect. 2017 Mar;23(3):209.e1-209.e7. doi: 10.1016/j.cmi.2016.11.006. Epub 2016 Nov 13.

44.

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. A Two-Edged Sword.

Riesbeck K.

Am J Respir Crit Care Med. 2016 Nov 15;194(10):1177-1178. No abstract available.

PMID:
27845580
45.

Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction.

Mühlenkamp MC, Hallström T, Autenrieth IB, Bohn E, Linke D, Rinker J, Riesbeck K, Singh B, Leo JC, Hammerschmidt S, Zipfel PF, Schütz MS.

J Innate Immun. 2017;9(1):33-51. doi: 10.1159/000449200. Epub 2016 Nov 1.

46.

Moraxella catarrhalis induces CEACAM3-Syk-CARD9-dependent activation of human granulocytes.

Heinrich A, Heyl KA, Klaile E, Müller MM, Klassert TE, Wiessner A, Fischer K, Schumann RR, Seifert U, Riesbeck K, Moter A, Singer BB, Bachmann S, Slevogt H.

Cell Microbiol. 2016 Nov;18(11):1570-1582. doi: 10.1111/cmi.12597. Epub 2016 May 3.

47.

Can dressings soaked with polyhexanide reduce bacterial loads in full-thickness skin grafting? A randomized controlled trial.

Saleh K, Sonesson A, Persson K, Riesbeck K, Schmidtchen A.

J Am Acad Dermatol. 2016 Dec;75(6):1221-1228.e4. doi: 10.1016/j.jaad.2016.07.020. Epub 2016 Sep 27.

PMID:
27692497
48.

FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.

Jusko M, Miedziak B, Ermert D, Magda M, King BC, Bielecka E, Riesbeck K, Eick S, Potempa J, Blom AM.

J Immunol. 2016 Oct 15;197(8):3245-3259. Epub 2016 Sep 16.

50.

Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.

Duell BL, Su YC, Riesbeck K.

FEBS Lett. 2016 Nov;590(21):3840-3853. doi: 10.1002/1873-3468.12351. Epub 2016 Aug 25. Review.

Supplemental Content

Loading ...
Support Center